These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6625846)

  • 1. [Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis].
    Kremp L; Girot R; Alliot S; Najean Y; Douchain F; Hongre JF
    Arch Fr Pediatr; 1983; 40(6):475-7. PubMed ID: 6625846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the use of iron-chelating agents for the treatment of iron overload.
    Modell B
    Prog Hematol; 1979; 11():267-312. PubMed ID: 392593
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vitamin B6-sensitive hereditary sideroblastic anemia].
    Heller T; Höchstetter V; Basler M; Borck V
    Dtsch Med Wochenschr; 2004 Jan; 129(4):141-4. PubMed ID: 14724775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload complicating sideroblastic anemia--is the gene for hemochromatosis responsible?
    Barron R; Grace ND; Sherwood G; Powell LW
    Gastroenterology; 1989 Apr; 96(4):1204-6. PubMed ID: 2925065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemochromatotic cirrhosis complicating pyridoxine-sensitive hereditary sideroblastic anemia. Case report].
    Abadia R; Rochant H; Levy VG
    Ann Med Interne (Paris); 1983; 134(4):327-32. PubMed ID: 6614712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An older female patient with refractory anemia and hemochromatosis].
    Sutor GC; Ceconi C; Flemming P; Wysk J; Fabel H; Schuppert F
    Dtsch Med Wochenschr; 2002 Aug; 127(34-35):1754-8. PubMed ID: 12192634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ; Weatherall DJ
    Haematologia (Budap); 1984; 17(1):17-24. PubMed ID: 6724353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia.
    El Sayed SM; Abou-Taleb A; Mahmoud HS; Baghdadi H; Maria RA; Ahmed NS; Nabo MM
    Med Hypotheses; 2014 Aug; 83(2):238-46. PubMed ID: 24857772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symposium on sideroblastic anemia. An autopsy case of primary acquired sideroblastic anemia associated with secondary hemochromatosis--ferrokinetic study and observation on iron sedimentation and tissue damages].
    Miyazaki T
    Rinsho Ketsueki; 1972 Dec; 13(6):1029-30. PubMed ID: 4675063
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation.
    Meo A; Ruggeri A; La Rosa MA; Zanghì L; Morabito N; Duca L
    Hemoglobin; 2006; 30(1):131-7. PubMed ID: 16540426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ; Göbel U; Christaras A; Janssen G
    Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and treatment of iron overload.
    Brown EB
    Adv Intern Med; 1980; 26():159-86. PubMed ID: 7013439
    [No Abstract]   [Full Text] [Related]  

  • 13. Does rapidly progressive iron overload in a young girl with sideroblastic anemia also signify the presence of hereditary hemochromatosis?
    Scimeca PG; Weinblatt ME; Kahn E; Kochen JA
    Pediatr Hematol Oncol; 1994; 11(1):99-104. PubMed ID: 8155505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine.
    Cesana M; Mandelli C; Tiribelli C; Bianchi PA; Conte D
    Am J Gastroenterol; 1989 Feb; 84(2):150-2. PubMed ID: 2916524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of deferoxamine in subcutaneous profusion treatment of iron overload in myelodysplastic syndromes].
    González FA; Arrizabalaga B; Villegas A; Alonso D; Castro M; Remacha A; del Arco A; Martín Núñez G;
    Med Clin (Barc); 2005 May; 124(17):645-7. PubMed ID: 15882510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
    Ault P; Jones K
    Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha.
    Keijzer A; van der Valk P; Ossenkoppele GJ; van de Loosdrecht AA
    Haematologica; 2006 Dec; 91(12 Suppl):ECR51. PubMed ID: 17194657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemochromatosis associated with primary sideroblastic anemia].
    Guañabens Calvet C; Soler Roca J; Brunet Mauri S; Binimelis Vidal J; Gimferrer Felip E; Domingo Albós A; Pujol-Moix N
    Sangre (Barc); 1984; 29(5):887-91. PubMed ID: 6523341
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M; Uchiyama T; Okamoto S; Kanakura Y; Sawada K; Tomonaga M; Nakao S; Nakahata T; Harada M; Murate T; Ozawa K;
    Eur J Haematol; 2007 Jun; 78(6):487-94. PubMed ID: 17391310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Turbina NS
    Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.